[HTML][HTML] Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across …

A Noori, AM Mezlini, BT Hyman, A Serrano-Pozo… - Neurobiology of …, 2021 - Elsevier
Neurodegenerative disorders such as Alzheimer's disease (AD), Lewy body diseases (LBD),
and the amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) spectrum are …

Therapeutic implications of phosphorylation-and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration

N Khakha, H Khan, A Kaur, TG Singh - Pharmacological Reports, 2023 - Springer
Neurodegeneration is a condition of the central nervous system (CNS) characterized by loss
of neural structures and function. The most common neurodegenerative disorders (NDDs) …

A glycomics and proteomics study of aging and Parkinson's disease in human brain

R Raghunathan, JD Hogan, A Labadorf, RH Myers… - Scientific Reports, 2020 - nature.com
Previous studies on Parkinson's disease mechanisms have shown dysregulated
extracellular transport of α-synuclein and growth factors in the extracellular space. In the …

Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease

NA Kaidery, M Ahuja, B Thomas - Molecular and Cellular Neuroscience, 2019 - Elsevier
Search for a definitive cure for neurodegenerative disorders like Parkinson's disease (PD)
has met with little success. Mitochondrial dysfunction and elevated oxidative stress precede …

RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS

M Kaisrlikova, J Vesela, D Kundrat, H Votavova… - Leukemia, 2022 - nature.com
Patients with lower-risk myelodysplastic syndromes (LR-MDS) have a generally favorable
prognosis; however, a small proportion of cases progress rapidly. This study aimed to define …

Transcriptomic profiles in Parkinson's disease

L Kurvits, F Lättekivi, E Reimann… - Experimental …, 2021 - journals.sagepub.com
Transcriptomics in Parkinson's disease offers insights into the pathogenesis of Parkinson's
disease but obtaining brain tissue has limitations. In order to bypass this issue, we profile …

RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

J Solana‐Balaguer, N Martín‐Flores… - Journal of …, 2023 - Wiley Online Library
Extracellular vesicles (EVs) play a crucial role in intercellular communication, participating in
the paracrine trophic support or in the propagation of toxic molecules, including proteins …

The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain

F Agus, D Crespo, RH Myers, A Labadorf - BMC medical genomics, 2019 - Springer
Background The mechanisms underlying neurodegeneration in the striatum of Huntingon's
Disease (HD) brain are currently unknown. While the striatum is massively degenerated in …

miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease

M Hart, C Diener, L Lunkes, S Rheinheimer… - Molecular …, 2023 - Springer
Background Although a pivotal role of microRNA (miRNA, miR) in the pathogenesis of
Huntington's disease (HD) is increasingly recognized, the molecular functions of miRNAs in …

A meta-analysis of transcriptomic profiles of Huntington's disease patients

M Seefelder, S Kochanek - PLoS One, 2021 - journals.plos.org
Description of robust transcriptomic alterations in Huntington's disease is essential to identify
targets for biochemical studies and drug development. We analysed publicly available …